SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-19-031811
Filing Date
2019-08-13
Accepted
2019-08-13 16:21:10
Documents
3
Period of Report
2019-08-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K Q2 2019 PRESS RELEASE alt-8k_20190813.htm 8-K 39052
2 EX-99.1 alt-ex991_6.htm EX-99.1 343194
3 GRAPHIC gkochlj53omr000001.jpg GRAPHIC 8685
  Complete submission text file 0001564590-19-031811.txt   395686
Mailing Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878
Business Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878 2406541450
Altimmune, Inc. (Filer) CIK: 0001326190 (see all company filings)

IRS No.: 202726770 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32587 | Film No.: 191020904
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1